Evidence map›Paper›PMID 39352512›Full record

ArticleMolecular cancer research : MCR2025

Gram-Negative Microflora Dysbiosis Facilitates Tumor Progression and Immune Evasion by Activating the CCL3/CCL5-CCR1-MAPK-PD-L1 Pathway in Esophageal Squamous Cell Carcinoma.

Huiqin Yang, Jiahao Cai, Xiaolong Huang, Cheng Zhan, Chunlai Lu, Jie Gu, Teng Ma, Hongyu Zhang, Tao Cheng, Fengkai Xu and 1 more

Abstract read
In one paragraph

Article in Molecular cancer research : MCR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Huiqin Yang *Zhongshan Hospital, Fudan University, Shanghai, China.ORCID 0000-0001-5241-1766
Jiahao Cai *Zhongshan Hospital, Fudan University, Shanghai, China.ORCID 0000-0002-5854-3775
Xiaolong Huang *Zhongshan Hospital, Fudan University, Shanghai, China.ORCID 0009-0007-7221-0145
Cheng ZhanZhongshan Hospital, Fudan University, Shanghai, China.ORCID 0000-0001-8745-9276
Chunlai LuZhongshan Hospital, Fudan University, Shanghai, China.ORCID 0000-0003-4230-5120
Jie GuZhongshan Hospital, Fudan University, Shanghai, China.ORCID 0000-0002-8852-5164
Teng MaZhongshan Hospital, Fudan University, Shanghai, China.ORCID 0000-0003-4415-0863
Hongyu ZhangZhongshan Hospital, Fudan University, Shanghai, China.ORCID 0009-0009-7924-6778
Tao ChengZhongshan Hospital, Fudan University, Shanghai, China.ORCID 0009-0001-7365-5134
Fengkai XuZhongshan Hospital, Fudan University, Shanghai, China.ORCID 0000-0002-0886-9013
Di GeZhongshan Hospital, Fudan University, Shanghai, China.ORCID 0009-0006-8768-5699

Funding

National Natural Science Foundation of China (NSFC) 81872291Natural Science Foundation for Young Scientists (Young Scientists Fund of the National Natural Science Foundation of China) 82003280
6 · The paper itself

Abstract

Gram-negative (G-) microflora dysbiosis occurs in multiple digestive tumors and is found to be the dominant microflora in the esophageal squamous cell carcinoma (ESCC) microenvironment. The continuous stimulation of G- bacterium metabolites may cause tumorigenesis and reshape the microimmune environment in ESCC. However, the mechanism of G- bacilli causing immune evasion in ESCC remains underexplored. We identified CC chemokine receptor 1 (CCR1) as a tumor-indicating gene in ESCC. Interestingly, expression levels of CCR1 and PD-L1 were mutually upregulated after G- bacilli metabolite lipopolysaccharide stimulation. First, we found that CCR1 high expression levels were associated with poor overall survival in ESCC. Importantly, we found that high levels of CCR1 expression upregulated PD-L1 expression by activating MAPK phosphorylation in ESCC and induced tumor malignant behavior. Finally, we found that T-cell exhaustion and cytotoxicity suppression were associated with CCR1 expression in ESCC, which were decreased after CCR1 inhibiting. Our work identifies CCR1 as a potential immune check point regulator of PD-L1 and may cause T-cell exhaustion and cytotoxicity suppression in ESCC microenvironment and highlights the potential value of CCR1 as a therapeutic target of immunotherapy. Implications: The esophageal microbial environment and its metabolites significantly affect the outcome of immunotherapy for ESCC.

Indexed as

B7-H1 AntigenDysbiosisEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaReceptors, CCR1AnimalsCell Line, TumorChemokine CCL5Disease ProgressionFemaleHumansImmune EvasionMaleMiceTumor EscapeTumor MicroenvironmentB7-H1 AntigenCCR1 protein, humanCD274 protein, humanChemokine CCL5Receptors, CCR1

Identifiers

PMID39352512
PMCPMC11694060

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.